What is the Org number of ApoXcel AB?

ApoXcel AB is registered with Bolagsverket / SCB under Org 5593341497.

What is the revenue of ApoXcel AB?

ApoXcel AB reported revenue of SEK 20,4M in 2024.

Humayun Iqbal is the CEO of ApoXcel AB, in role since 2022.

ApoXcel AB's registered address is Kvarngatan 23 Lgh 1104.

ABActive

Org 5593341497Kvarngatan 23, 692 34 KumlaRetail sale of pharmaceutical products· NACE 4773Est. 2021 · 4 years old1-4 employees

Actively employed in the business

Name	Role	Member since
Current (3)
HI Humayun Iqbal Chief Executive Officer	Chief Executive Officer	2022
JK Jon Karl Lahiru Nilsson Chief Auditor	Chief Auditor	2025
JL Jonas Lars Lindgren Chief Auditor	Chief Auditor	2022

Non-executive oversight

Name	Role	Member since
Current (2)
NH Nyla Humayun Deputy Board Member	Deputy Board Member	2022
NH Nyla Humayun Deputy Board Member	Deputy Board Member	2022

Former (12)


HJ Hans Jarl Rutger Arnhult Deputy Board Member	Deputy Board Member	2021 – 2022
BD Bo Daniel Falk Deputy Board Member	Deputy Board Member	2021 – 2022
VE Viktor Elias Bergman Gullmark Deputy Board Member	Deputy Board Member	2021 – 2022
EM Emma Maria Birgitta Wik Deputy Board Member	Deputy Board Member	2021 – 2022
AM Anna Matilda Sjödin Deputy Board Member	Deputy Board Member	2021 – 2022
LA Lars Anders Larsson Board of Directors	Board of Directors	2021 – 2022
ES Emelie Sofia Bergh Deputy Board Member	Deputy Board Member	2021 – 2022
AC Anna Carolina Maria Bjarnhagen Deputy Board Member	Deputy Board Member	2021 – 2022
RS Rolf Stefan Janse Deputy Board Member	Deputy Board Member	2021 – 2022
MS Mari Sinikka Kovaniemi Feldt Deputy Board Member	Deputy Board Member	2021 – 2022
OK Olina Kristina Maria Wåhlstedt Deputy Board Member	Deputy Board Member	2021 – 2022
ES Elin Sofia Gyllenqvist Deputy Board Member	Deputy Board Member	2021 – 2022

As of last annual report

Shareholder	Type	Ownership	Votes	Since
Apolans AB	Company	99%	99%	2025

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.